2005
$41M
from 5 investors over 5 rounds
Aerie Pharmaceuticals raised $41M on March 7, 2011
Investors: Sofinnova Ventures, Russia technology fund, Clarus Ventures, LLC, Alta Partners and Osage University Partners (OUP)
Aerie Pharmaceuticals raised undisclosed on January 1, 2010
Investors: Sofinnova Ventures, Russia technology fund